122 related articles for article (PubMed ID: 8773464)
1. Complex ionic control of [3H]GBR 12783 binding to the dopamine neuronal carrier.
Héron C; Billaud G; Costentin J; Bonnet JJ
Eur J Pharmacol; 1996 Apr; 301(1-3):195-202. PubMed ID: 8773464
[TBL] [Abstract][Full Text] [Related]
2. Interaction of two sulfhydryl reagents with a cation recognition site on the neuronal dopamine carrier evidences small differences between [3H]GBR 12783 and [3H]cocaine binding sites.
Refahi-Lyamani F; Saadouni S; Costentin J; Bonnet JJ
Naunyn Schmiedebergs Arch Pharmacol; 1995 Feb; 351(2):136-45. PubMed ID: 7770096
[TBL] [Abstract][Full Text] [Related]
3. Effect of CH3HgCl and several transition metals on the dopamine neuronal carrier; peculiar behaviour of Zn2+.
Bonnet JJ; Benmansour S; Amejdki-Chab N; Costentin J
Eur J Pharmacol; 1994 Jan; 266(1):87-97. PubMed ID: 8137886
[TBL] [Abstract][Full Text] [Related]
4. Specific binding of [3H]GBR 12783 to the dopamine neuronal carrier included in polarized membranes.
Billaud G; Costentin J; Bonnet JJ
Eur J Pharmacol; 1993 Nov; 247(3):333-40. PubMed ID: 8307105
[TBL] [Abstract][Full Text] [Related]
5. Binding of uptake blockers to the neuronal dopamine transporter: further investigation about cationic and anionic requirements.
Corera AT; Costentin J; Bonnet JJ
Naunyn Schmiedebergs Arch Pharmacol; 2000 Sep; 362(3):213-21. PubMed ID: 10997723
[TBL] [Abstract][Full Text] [Related]
6. Cocaine and GBR 12783 recognize nonidentical, overlapping binding domains on the dopamine neuronal carrier.
Saadouni S; Refahi-Lyamani F; Costentin J; Bonnet JJ
Eur J Pharmacol; 1994 Jul; 268(2):187-97. PubMed ID: 7957640
[TBL] [Abstract][Full Text] [Related]
7. Evidence for the sequential formation of two complexes between an uptake inhibitor, GBR 12783 [1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-2-propenyl)piperazine], and the neuronal transporter of dopamine.
Do-Régo JC; Hue H; Costentin J; Bonnet JJ
J Neurochem; 1999 Jan; 72(1):396-404. PubMed ID: 9886093
[TBL] [Abstract][Full Text] [Related]
8. Effects of several cations on the neuronal uptake of dopamine and the specific binding of [3H]GBR 12783: attempts to characterize the Na+ dependence of the neuronal transport of dopamine.
Amejdki-Chab N; Benmansour S; Costentin J; Bonnet JJ
J Neurochem; 1992 Nov; 59(5):1795-804. PubMed ID: 1402923
[TBL] [Abstract][Full Text] [Related]
9. Thermodynamics of the binding of BTCP (GK 13) and related derivatives on the dopamine neuronal carrier.
Billaud G; Menard JF; Marcellin N; Kamenka JM; Costentin J; Bonnet JJ
Eur J Pharmacol; 1994 Aug; 268(3):357-63. PubMed ID: 7805759
[TBL] [Abstract][Full Text] [Related]
10. The dopamine transporter and cytochrome P45OIID1 (debrisoquine 4-hydroxylase) in brain: resolution and identification of two distinct [3H]GBR-12935 binding proteins.
Niznik HB; Tyndale RF; Sallee FR; Gonzalez FJ; Hardwick JP; Inaba T; Kalow W
Arch Biochem Biophys; 1990 Feb; 276(2):424-32. PubMed ID: 2306106
[TBL] [Abstract][Full Text] [Related]
11. Evidence that pure uptake inhibitors including cocaine interact slowly with the dopamine neuronal carrier.
Héron C; Costentin J; Bonnet JJ
Eur J Pharmacol; 1994 Nov; 264(3):391-8. PubMed ID: 7698180
[TBL] [Abstract][Full Text] [Related]
12. In vivo labelling of the neuronal dopamine uptake complex in the mouse striatum by [3H]GBR 12783.
Vaugeois JM; Bonnet JJ; Costentin J
Eur J Pharmacol; 1992 Jan; 210(1):77-84. PubMed ID: 1350989
[TBL] [Abstract][Full Text] [Related]
13. Thermodynamic analyses of the binding of substrates and uptake inhibitors on the neuronal carrier of dopamine labeled with [3H]GBR 12783 or [3H]mazindol.
Bonnet JJ; Benmansour S; Costentin J; Parker EM; Cubeddu LX
J Pharmacol Exp Ther; 1990 Jun; 253(3):1206-14. PubMed ID: 2141637
[TBL] [Abstract][Full Text] [Related]
14. Photoaffinity labeling of the dopamine reuptake carrier protein with 3-azido[3H]GBR-12935.
Berger SP; Martenson RE; Laing P; Thurkauf A; Decosta B; Rice KC; Paul SM
Mol Pharmacol; 1991 Apr; 39(4):429-35. PubMed ID: 2017146
[TBL] [Abstract][Full Text] [Related]
15. Translocation of dopamine and binding of 2 beta-carbomethoxy-3 beta-(4-fluorophenyl) tropane (WIN 35,428) measured under identical conditions in rat striatal synaptosomal preparations. Inhibition by various blockers.
Xu C; Coffey LL; Reith ME
Biochem Pharmacol; 1995 Jan; 49(3):339-50. PubMed ID: 7857321
[TBL] [Abstract][Full Text] [Related]
16. Ionic requirements for the specific binding of [3H]GBR 12783 to a site associated with the dopamine uptake carrier.
Bonnet JJ; Benmansour S; Vaugeois JM; Costentin J
J Neurochem; 1988 Mar; 50(3):759-65. PubMed ID: 3339350
[TBL] [Abstract][Full Text] [Related]
17. Modeling of the interaction of Na+ and K+ with the binding of dopamine and [3H]WIN 35,428 to the human dopamine transporter.
Li LB; Reith ME
J Neurochem; 1999 Mar; 72(3):1095-109. PubMed ID: 10037481
[TBL] [Abstract][Full Text] [Related]
18. Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]-and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909).
Matecka D; Rothman RB; Radesca L; de Costa BR; Dersch CM; Partilla JS; Pert A; Glowa JR; Wojnicki FH; Rice KC
J Med Chem; 1996 Nov; 39(24):4704-16. PubMed ID: 8941383
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding.
Pristupa ZB; Wilson JM; Hoffman BJ; Kish SJ; Niznik HB
Mol Pharmacol; 1994 Jan; 45(1):125-35. PubMed ID: 8302271
[TBL] [Abstract][Full Text] [Related]
20. Differential sensitivity to NaCl for inhibitors and substrates that recognize mutually exclusive binding sites on the neuronal transporter of dopamine in rat striatal membranes.
Tidjane Corera A; Do-Régo JC; Costentin J; Bonnet JJ
Neurosci Res; 2001 Mar; 39(3):319-25. PubMed ID: 11248372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
